Literature DB >> 34237115

Definition of the immune evasion-replication interface of rabies virus P protein.

Jingyu Zhan1,2, Angela R Harrison3, Stephanie Portelli1,2, Thanh Binh Nguyen1,2, Isshu Kojima4, Siqiong Zheng1,2, Fei Yan1,2, Tatsunori Masatani5, Stephen M Rawlinson3, Ashish Sethi1,2, Naoto Ito5, David B Ascher1,2, Gregory W Moseley3, Paul R Gooley1,2.   

Abstract

Rabies virus phosphoprotein (P protein) is a multifunctional protein that plays key roles in replication as the polymerase cofactor that binds to the complex of viral genomic RNA and the nucleoprotein (N protein), and in evading the innate immune response by binding to STAT transcription factors. These interactions are mediated by the C-terminal domain of P (PCTD). The colocation of these binding sites in the small globular PCTD raises the question of how these interactions underlying replication and immune evasion, central to viral infection, are coordinated and, potentially, coregulated. While direct data on the binding interface of the PCTD for STAT1 is available, the lack of direct structural data on the sites that bind N protein limits our understanding of this interaction hub. The PCTD was proposed to bind via two sites to a flexible loop of N protein (Npep) that is not visible in crystal structures, but no direct analysis of this interaction has been reported. Here we use Nuclear Magnetic Resonance, and molecular modelling to show N protein residues, Leu381, Asp383, Asp384 and phosphor-Ser389, are likely to bind to a 'positive patch' of the PCTD formed by Lys211, Lys214 and Arg260. Furthermore, in contrast to previous predictions we identify a single site of interaction on the PCTD by this Npep. Intriguingly, this site is proximal to the defined STAT1 binding site that includes Ile201 to Phe209. However, cell-based assays indicate that STAT1 and N protein do not compete for P protein. Thus, it appears that interactions critical to replication and immune evasion can occur simultaneously with the same molecules of P protein so that the binding of P protein to activated STAT1 can potentially occur without interrupting interactions involved in replication. These data suggest that replication complexes might be directly involved in STAT1 antagonism.

Entities:  

Year:  2021        PMID: 34237115     DOI: 10.1371/journal.ppat.1009729

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  84 in total

1.  Functional interaction map of lyssavirus phosphoprotein: identification of the minimal transcription domains.

Authors:  Y Jacob; E Real; N Tordo
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Crystal structure of the rabies virus nucleoprotein-RNA complex.

Authors:  Aurélie A V Albertini; Amy K Wernimont; Tadeusz Muziol; Raimond B G Ravelli; Cedric R Clapier; Guy Schoehn; Winfried Weissenhorn; Rob W H Ruigrok
Journal:  Science       Date:  2006-06-15       Impact factor: 47.728

3.  Clustal W and Clustal X version 2.0.

Authors:  M A Larkin; G Blackshields; N P Brown; R Chenna; P A McGettigan; H McWilliam; F Valentin; I M Wallace; A Wilm; R Lopez; J D Thompson; T J Gibson; D G Higgins
Journal:  Bioinformatics       Date:  2007-09-10       Impact factor: 6.937

4.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

5.  Human rabies: 2016 updates and call for data.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2017-02-17

6.  1H, 15N and 13C resonance assignments of the C-terminal domain of the P protein of the Nishigahara strain of rabies virus.

Authors:  Jingyu Zhan; Md Alamgir Hossain; Ashish Sethi; Toyoyuki Ose; Gregory W Moseley; Paul R Gooley
Journal:  Biomol NMR Assign       Date:  2018-09-20       Impact factor: 0.746

7.  Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits STAT dephosphorylation.

Authors:  Sook-Young Sohn; Patrick Hearing
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

8.  Both viral transcription and replication are reduced when the rabies virus nucleoprotein is not phosphorylated.

Authors:  Xianfu Wu; Xiaoming Gong; Heather D Foley; Matthias J Schnell; Zhen F Fu
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

9.  Proteolytic cleavage of subunits of the nucleocapsid of the paramyxovirus simian virus 5.

Authors:  W E Mountcastle; R W Compans; H Lackland; P W Choppin
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

View more
  4 in total

1.  The Amino Acid at Position 95 in the Matrix Protein of Rabies Virus Is Involved in Antiviral Stress Granule Formation in Infected Cells.

Authors:  Isshu Kojima; Koji Onomoto; Wenjie Zuo; Makoto Ozawa; Kosuke Okuya; Kiyotada Naitou; Fumiki Izumi; Misuzu Okajima; Takuro Fujiwara; Naoto Ito; Mitsutoshi Yoneyama; Kentaro Yamada; Akira Nishizono; Makoto Sugiyama; Takashi Fujita; Tatsunori Masatani
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

2.  Molecular Basis of Functional Effects of Phosphorylation of the C-Terminal Domain of the Rabies Virus P Protein.

Authors:  Jingyu Zhan; Ericka Watts; Aaron M Brice; Riley D Metcalfe; Ashley M Rozario; Ashish Sethi; Fei Yan; Toby D M Bell; Michael D W Griffin; Gregory W Moseley; Paul R Gooley
Journal:  J Virol       Date:  2022-04-11       Impact factor: 6.549

3.  Deactivation of the antiviral state by rabies virus through targeting and accumulation of persistently phosphorylated STAT1.

Authors:  Gayathri Manokaran; Michelle D Audsley; Haruka Funakoda; Cassandra T David; Katherine A Garnham; Stephen M Rawlinson; Celine Deffrasnes; Naoto Ito; Gregory W Moseley
Journal:  PLoS Pathog       Date:  2022-05-16       Impact factor: 7.464

Review 4.  Research Advances on the Interactions between Rabies Virus Structural Proteins and Host Target Cells: Accrued Knowledge from the Application of Reverse Genetics Systems.

Authors:  Juanbin Yin; Xiangwei Wang; Ruoqing Mao; Zhixiong Zhang; Xin Gao; Yingying Luo; Yuefeng Sun; Xiangping Yin
Journal:  Viruses       Date:  2021-11-16       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.